Literature DB >> 25317875

The target of metformin in type 2 diabetes.

Ele Ferrannini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25317875     DOI： 10.1056/NEJMcibr1409796

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes.

Authors:  Daniel M Rotroff; Sook Wah Yee; Kaixin Zhou; Skylar W Marvel; Hetal S Shah; John R Jack; Tammy M Havener; Monique M Hedderson; Michiaki Kubo; Mark A Herman; He Gao; Josyf C Mychaleckyi; Howard L McLeod; Alessandro Doria; Kathleen M Giacomini; Ewan R Pearson; Michael J Wagner; John B Buse; Alison A Motsinger-Reif
Journal:  Diabetes       Date:  2018-04-12       Impact factor: 9.461

2.  Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Authors:  Corinna Seliger; Anne-Louise Meyer; Kathrin Renner; Verena Leidgens; Sylvia Moeckel; Birgit Jachnik; Katja Dettmer; Ulrike Tischler; Valeria Gerthofer; Lisa Rauer; Martin Uhl; Martin Proescholdt; Ulrich Bogdahn; Markus J Riemenschneider; Peter J Oefner; Marina Kreutz; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

3.  Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation.

Authors:  Huimin Yan; Hui-Fang Zhou; Ying Hu; Christine T N Pham
Journal:  J Rheum Dis Treat       Date:  2015-02-28

4.  Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.

Authors:  José A Luchsinger; Thania Perez; Helena Chang; Pankaj Mehta; Jason Steffener; Gnanavalli Pradabhan; Masanori Ichise; Jennifer Manly; Davangere P Devanand; Emilia Bagiella
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 5.  The therapeutic potential of metformin in gastric cancer.

Authors:  Sarah Courtois; Philippe Lehours; Emilie Bessède
Journal:  Gastric Cancer       Date:  2019-03-21       Impact factor: 7.370

6.  Fibroblasts rescue oral squamous cancer cell from metformin-induced apoptosis via alleviating metabolic disbalance and inhibiting AMPK pathway.

Authors:  Zhuoyuan Zhang; Xiao Liang; Yaping Fan; Zhenjie Gao; Laurence A Bindoff; Daniela Elena Costea; Longjiang Li
Journal:  Cell Cycle       Date:  2019-04-23       Impact factor: 4.534

Review 7.  Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Authors:  Abd A Tahrani; Anthony H Barnett; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2016-06-24       Impact factor: 43.330

8.  Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.

Authors:  Elza Muscelli; Brenno Astiarraga; Elisabetta Barsotti; Andrea Mari; Freimut Schliess; Leszek Nosek; Tim Heise; Uli C Broedl; Hans-Juergen Woerle; Ele Ferrannini
Journal:  Diabetologia       Date:  2015-12-24       Impact factor: 10.122

9.  Untargeted Metabolomic Approach Shows No Differences in Subcutaneous Adipose Tissue of Diabetic and Non-Diabetic Subjects Undergoing Bariatric Surgery: An Exploratory Study.

Authors:  Carlotta Vizioli; Rosario B Jaime-Lara; Alexis T Franks; Rodrigo Ortiz; Paule V Joseph
Journal:  Biol Res Nurs       Date:  2020-08-07       Impact factor: 2.522

10.  In Vitro & In Vivo Anti-Hyperglycemic Potential of Saponins Cake and Argan Oil from Argania spinosa.

Authors:  Rabie Kamal; Mourad Kharbach; Yvan Vander Heyden; Huiwen Yu; Abdelaziz Bouklouze; Yahia Cherrah; Katim Alaoui
Journal:  Foods       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.